KING PHARMACEUTICALS INC Contracts & Agreements

Financial Statements (Filed With SEC on May 6, 2010)

Current Salary (Filed With SEC on March 23, 2010)

research and development (Filed With SEC on February 26, 2010)

Financial Statements (Filed With SEC on May 11, 2009)

research and development (Filed With SEC on March 2, 2009)

EX-2.1: AGREEMENT AND PLAN OF MERGER (Filed With SEC on November 24, 2008)

EX-10.1: AMENDED AND RESTATED COMMITMENT LETTER (Filed With SEC on November 24, 2008)

IN THE CHANCERY COURT FOR SULLIVAN COUNTY AT BRISTOL, TENNESSEE IN RE: KING PHARMACEUTICALS, INC. DERIVATIVE LITIGATION Lead Case No. BOO19077(M) This document relates to:... (Filed With SEC on August 27, 2008)

EX-10.1 PRODUCT DEVELOPMENT AGREEMENT (Filed With SEC on August 7, 2008)

EX-10.2 DIRECTOR COMPENSATION POLICY (Filed With SEC on August 7, 2008)

KING PHARMACEUTICALS, INC. INCENTIVE PLAN RESTRICTED UNIT CERTIFICATE (Filed With SEC on May 21, 2008)

2008 EXECUTIVE MANAGEMENT INCENTIVE AWARDS (Filed With SEC on May 8, 2008)

Director Compensation Policy for Non-Employee Directors of King Pharmaceuticals, Inc. As Approved by the Board of Directors on February 13, 2004 and amended on July 22, 2005,... (Filed With SEC on May 8, 2008)

KING PHARMACEUTICALS, INC. INCENTIVE PLAN OPTION CERTIFICATE (Filed With SEC on April 1, 2008)

KING PHARMACEUTICALS, INC. INCENTIVE PLAN RESTRICTED STOCK CERTIFICATE (Filed With SEC on April 1, 2008)

KING PHARMACEUTICALS, INC. INCENTIVE PLAN LONG-TERM PERFORMANCE UNIT AWARD CERTIFICATE (ONE-YEAR PERFORMANCE CYCLE) (Filed With SEC on April 1, 2008)

KING PHARMACEUTICALS, INC. INCENTIVE PLAN LONG-TERM PERFORMANCE UNIT AWARD CERTIFICATE (THREE-YEAR PERFORMANCE CYCLE) (Filed With SEC on April 1, 2008)

Termination of Litigation (Filed With SEC on January 8, 2008)

METAXALONE 800 mg PRODUCT AGREEMENT (Filed With SEC on January 8, 2008)

King Pharmaceuticals, Inc. Non- Employee Directors Deferred Compensation Plan (Filed With SEC on December 5, 2007)

KING PHARMACEUTICALS, INC. INCENTIVE PLAN RESTRICTED STOCK CERTIFICATE (Filed With SEC on December 5, 2007)

LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN (Filed With SEC on November 5, 2007)

- 1 - (Filed With SEC on November 5, 2007)

Ex-10.1 King Pharmaceuticals, Inc.Amended and Restated Severance Pay Plan: Tier 1 (Filed With SEC on October 22, 2007)

ASSET PURCHASE AGREEMENT by and among KING PHARMACEUTICALS, INC. MONARCH PHARMACEUTICALS, INC., PARKEDALE PHARMACEUTICALS, INC., and KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT,... (Filed With SEC on July 19, 2007)

KING PHARMACEUTICALS, INC. INCENTIVE PLAN RESTRICTED STOCK CERTIFICATE (Filed With SEC on May 21, 2007)

KING PHARMACEUTICALS, INC. INCENTIVE PLAN LONG-TERM PERFORMANCE UNIT AWARD CERTIFICATE (ONE-YEAR PERFORMANCE CYCLE) (Filed With SEC on May 21, 2007)

KING PHARMACEUTICALS, INC. INCENTIVE PLAN LONG-TERM PERFORMANCE UNIT AWARD CERTIFICATE (THREE YEAR PERFORMANCE CYCLE) (Filed With SEC on May 21, 2007)

KING PHARMACEUTICALS, INC. INCENTIVE PLAN RESTRICTED UNIT CERTIFICATE (Filed With SEC on May 21, 2007)

Director Compensation Policy for Non-Employee Directors of King Pharmaceuticals, Inc. As Approved by the Board of Directors on February 13, 2004 and amended on July 22, 2005,... (Filed With SEC on May 21, 2007)

Ex-10.8 2007 Executive Management Incentive Award (Filed With SEC on May 10, 2007)

EX-10.1 FORM OF OPINION AND NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on March 27, 2007)

EX-10.2 FORM OF RESTRICTED STOCK CERTIFICATE AND RESTRICTED STOCK GRANT AGREEMENT (Filed With SEC on March 27, 2007)

EX-10.3 FORM OF LONG-TERM PERFORMANCE UNIT AWARD AGREEMENT (Filed With SEC on March 27, 2007)

EX-10.4 FORM OF LONG-TERM PERFORMANCE UNIT AWARD AGREEMENT (Filed With SEC on March 27, 2007)

Ex-2.1 Amendment No. 2 to Purchase Agreement (Filed With SEC on March 2, 2007)

Ex-2.1 Amendment No. 1 to Purchase Agreement, Contract Sales Force Agreement and Confidentiality Agreement (Filed With SEC on January 5, 2007)

Ex-2.2 Side Letter among King and Ligand dated December 29, 2006 (Filed With SEC on January 5, 2007)

Ex-10.1 Amended Co-Promotion Agreement (Filed With SEC on November 9, 2006)

Ex-10.2 July 31, 2006 Settelement Agreement (Filed With SEC on November 9, 2006)

Ex-10.4 Form of Restricted Unit Certificate/Grant Agreement (Filed With SEC on November 9, 2006)

Ex-2.1 Purchase Agreement (Filed With SEC on September 12, 2006)

EX-10.1 PROMOTION AGREEMENT 06/27/06 (Filed With SEC on August 9, 2006)

EX-10.2 FORM OF RESTRICTED UNIT CERTIFICATE AND RESTRICTED UNIT GRANT AGREEMENT (Filed With SEC on August 9, 2006)

Director Compensation Policy for Non-Employee Directors of King Pharmaceuticals, Inc. As Approved by the Board of Directors on February 13, 2004 and amended on July 22, 2005,... (Filed With SEC on August 8, 2006)

Ex-10.1 Generic Distribution Agreement (Filed With SEC on May 10, 2006)

Ex-10.2 Product Supply Agreement (Filed With SEC on May 10, 2006)

Ex-10.3 Ramipril Application License Agreement (Filed With SEC on May 10, 2006)

Ex-10.4 Ramipril Patient License Agreement (Filed With SEC on May 10, 2006)

Ex-10.5 Dismissal Agreement (Filed With SEC on May 10, 2006)

Ex-10.6 Amended and Restated Manufacturing Agreement (Filed With SEC on May 10, 2006)

Ex-10.7 First Amendment to the US Product Agreement (Filed With SEC on May 10, 2006)

Ex-10.8 Form of Performance Agreement (Filed With SEC on May 10, 2006)

Ex-10.9 Form of Performance Agreement (Filed With SEC on May 10, 2006)

Ex-4.1 Indenture dated as of March 29, 2006 (Filed With SEC on March 30, 2006)

Ex-4.2 Registration Rights Agreement dated as of March 29, 2006 (Filed With SEC on March 30, 2006)

EX-10.33 WAIVER AGREEMENT - JOHN A. A. BELLAMY (Filed With SEC on March 3, 2006)

EX-10.34 ADDENDUM TO THE WAIVER AGREEMENT (Filed With SEC on March 3, 2006)

EX-10.35 COLLABORATION AGREEMENT - PAIN THERAPEUTICS, INC (Filed With SEC on March 3, 2006)

EX-10.36 LICENSE AGREEMENT - PAIN THERAPEUTICS, INC (Filed With SEC on March 3, 2006)

EX-10.37 LICENSE AGREEMENT - MUTUAL PHARMACEUTICAL COMPANY, INC (Filed With SEC on March 3, 2006)

EX-10.38 JOHN A.A.BELLAMY SEVERANCE LETTER (Filed With SEC on March 3, 2006)

EX-10.2 FIRST AMENDMENT TO RETIREMENT AND CONSULTING (Filed With SEC on February 15, 2006)

EX-10.2 FIRST AMENDMENT TO RETIREMENT AND CONSULTING AGREEMENT (Filed With SEC on November 10, 2005)

SETTLEMENT AGREEMENT I. PARTIES (Filed With SEC on November 4, 2005)

STATE SETTLEMENT AGREEMENT I. THE PARTIES (Filed With SEC on November 4, 2005)

CORPORATE INTEGRITY AGREEMENT between the Office of Inspector General of the Department of Health and Human Services and King Pharmaceuticals, Inc. (Filed With SEC on November 4, 2005)

EX-10.1 INCENTIVE PLAN RESTRICTED STOCK CERTIFICATE (Filed With SEC on October 9, 2005)

EX-10.2 INCENTIVE PLAN OPTION CERTIFICATE (Filed With SEC on October 9, 2005)

Ex-10.1 Offer letter to Joseph Squicciarino dated May 6, 2005 (Filed With SEC on August 9, 2005)

Ex-10.2 Offer letter to Eric J. Bruce dated May 19, 2005 (Filed With SEC on August 9, 2005)

Ex-10.3 Retirement and Consulting Agreement, dated April 5, 2005 by and between King Pharmaceuticals, Inc. and James R. Lattanzi (Filed With SEC on August 9, 2005)

Ex-10.4 2005 Executive Management Incentive Award (Filed With SEC on August 9, 2005)

Ex-10.6 Compensation Policy for Non-Employee Directors (Filed With SEC on August 9, 2005)

Ex-10.7 Salary Amendments to Employment Arrangements with Certain Executive Officers (Filed With SEC on August 9, 2005)

Ex-10.8 King Pharmaceuticals, Inc. Executive Deferred Compensation Plan (Filed With SEC on August 9, 2005)

EX-2.1 Amended & Restated Asset Purch. Agreement (Filed With SEC on June 13, 2003)

Category

Industry

Companies

Contracts

KING PHARMACEUTICALS INC Contracts & Agreements